INMED PHARMACEUTICALS INC. Payments for Repurchase of Private Placement
INMED PHARMACEUTICALS INC. (INM) reported Payments for Repurchase of Private Placement of $264.56 thousand for the 9-month period ending 2025-03-31, per its 10-Q filed 2025-05-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForRepurchaseOfPrivatePlacement · last filed 2025-05-12
- INMED PHARMACEUTICALS INC. payments for repurchase of private placement for the quarter ending 2025-03-31 was $15.10K.
- INMED PHARMACEUTICALS INC. payments for repurchase of private placement for the quarter ending 2024-03-31 was $0.00.
| Period end | Payments for Repurchase of Private Placement 3 month | Payments for Repurchase of Private Placement 6 month | Payments for Repurchase of Private Placement 9 month |
|---|---|---|---|
| 2025-03-31 | $15.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-12 | $264.56K 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $249.46K 10-Q · filed 2025-02-12 | ||
| 2024-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-12 | $562.15K 10-Q · filed 2025-05-12 | |
| 2023-12-31 | $562.15K 10-Q · filed 2025-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |